BCL7A Antikörper (N-Term)
-
- Target Alle BCL7A Antikörper anzeigen
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
-
Bindungsspezifität
- AA 1-30, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser BCL7A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to Bcl-7A.
- Kreuzreaktivität (Details)
- Species reactivity (tested):Human.
- Aufreinigung
- Affinity chromatography on Protein A
- Immunogen
- KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCL7A
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product BCL7A Primärantikörper
-
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibody
BCL7A Reaktivität: Human, Maus, Ratte WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibodyVerified BCL7A Reaktivität: Human WB, ELISA, IF, FACS Wirt: Ziege Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (Middle Region) antibodyBCL7A Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein, Meerschweinchen, Pferd, Kaninchen, Zebrafisch (Danio rerio) WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 1-210) antibodyBCL7A Reaktivität: Human WB, IHC, ICC, IP Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 1-30), (N-Term) antibodyBCL7A Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB24969 unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (C-Term) antibodyBCL7A Reaktivität: Human, Maus WB, ELISA, ICC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 107-156) antibodyBCL7A Reaktivität: Human, Affe, Fledermaus WB Wirt: Kaninchen Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 7A (BCL7A) (AA 71-120) antibodyBCL7A Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Schwein, Meerschweinchen, Pferd, Kaninchen, Affe, Zebrafisch (Danio rerio), Huhn WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
- Target
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
- Andere Bezeichnung
- Bcl-7A (BCL7A Produkte)
- Hintergrund
- This gene is directly involved, with Myc and IgH, in a three-way gene translocation in a Burkitt lymphoma cell line. As a result of the gene translocation, the N-terminal region of the gene product is disrupted, which is thought to be related to the pathogenesis of a subset of high-grade B cell non-Hodgkin lymphoma. The N-terminal segment involved in the translocation includes the region that shares a strong sequence similarity with those of BCL7B and BCL7C. Two transcript variants encoding different isoforms have been found for this gene.Synonyms: B-cell CLL/lymphoma 7 protein family member A, BCL7A
- Gen-ID
- 605
- NCBI Accession
- NP_001019979
-
